Ücretsiz Kullanmaya Başla

Cloning and stem cells Knowledge-Based Study

Biology · Molecular Genetics · Biology · Biotechnology

Biology topic explanations on Cloning and stem cells.

Study notes

  1. What is Cloning?

    In biotechnology, cloning refers to the production of genetically identical copies of a biological entity. Depending on the scale and intended goal of the process, cloning is generally divided into three major categories:

    • Gene (DNA) Cloning: Copying specific DNA sequences or genes using recombinant DNA technology, cloning vectors (such as bacterial plasmids), and restriction enzymes.
    • Reproductive Cloning: Generating an entire multicellular organism that is genetically identical to a donor organism.
    • Therapeutic Cloning: Producing cloned embryos solely to harvest embryonic stem cells for research and regenerative medicine, without allowing the embryo to develop into a mature organism.

    While natural clones exist in biology—such as identical (monozygotic) twins and organisms undergoing asexual reproduction—artificial cloning techniques allow targeted replication of specific genetic material or somatic cell genomes.

    Somatic Cell Nuclear Transfer (SCNT)

    The primary laboratory technique used for cloning mammals is Somatic Cell Nuclear Transfer (SCNT). This procedure was famously utilized to produce Dolly the sheep in 1996, proving that fully differentiated adult somatic cells retain the complete genomic program needed to direct embryonic development.

    Key Steps in SCNT:

    1. Enucleation: An unfertilized egg cell (oocyte) is collected from an egg donor, and its haploid nucleus is removed using a microcapillary needle.
    2. Nuclear Transfer: A diploid nucleus is isolated from a differentiated somatic cell (such as a skin or mammary gland cell) of the genetic donor and introduced into the enucleated oocyte.
    3. Reprogramming and Activation: An electrical or chemical pulse stimulates the egg cell to fuse with the somatic nucleus and begin cell division, mimicking fertilization. Cytoplasmic factors inside the egg reprogram the somatic genome to an embryonic state.
    4. Implantation: The developing early embryo (blastocyst) is transferred into the uterus of a surrogate female, where it gestates until birth.

    Genetic Note: The resulting clone possesses nuclear DNA identical to the somatic cell donor. However, its mitochondrial DNA is derived from the donor of the enucleated egg cell.

    Properties of Stem Cells

    Stem cells are undifferentiated or partially differentiated cells capable of two defining biological functions: self-renewal (dividing indefinitely while remaining undifferentiated) and differentiation (maturing into specialized cell types).

    Levels of Potency:

    • Totipotent Stem Cells: Can differentiate into any cell type of the organism as well as extraembryonic tissues (such as the placenta). An example is the zygote and the cells of the first few divisions up to the morula stage.
    • Pluripotent Stem Cells: Can give rise to all three germ layers (ectoderm, mesoderm, and endoderm) of the embryo proper, but cannot form placental tissue. An example is the inner cell mass (ICM) of a blastocyst (embryonic stem cells).
    • Multipotent Stem Cells: Restricted to differentiating into a limited range of specialized cell lineages within a specific tissue. Examples include hematopoietic stem cells in bone marrow, which generate various blood cells.

    Reprogramming and Regenerative Medicine

    Historically, isolating human embryonic stem cells required the destruction of pre-implantation embryos, raising significant bioethical concerns. A major breakthrough occurred in 2006 with the development of Induced Pluripotent Stem Cells (iPSCs).

    Induced Pluripotent Stem Cells (iPSCs)

    Researchers discovered that adult somatic cells (such as dermal fibroblasts) can be reverted into a pluripotent state by introducing four specific transcription factors (Oct4, Sox2, Klf4, and c-Myc, often called the Yamanaka factors). These reprogrammed cells behave like embryonic stem cells without requiring an embryonic donor.

    Biomedical Applications:

    • Disease Modeling: Patient-derived iPSCs allow scientists to recreate genetic disorders in vitro and observe disease progression.
    • Drug Screening: Testing pharmaceuticals on human cell lines generated from patient stem cells reduces toxicity risks prior to clinical trials.
    • Autologous Cell Therapies: Replacing damaged tissues (such as pancreatic beta cells in diabetes or dopaminergic neurons in Parkinson's disease) using patient-matched cells eliminates the risk of immune rejection.